The Long-Standing TAA “Substantial Transformation” Standard for Drug Products is Challenged at the Court of International Trade

Published date16 March 2018
Law FirmCovington & Burling LLP
AuthorJennifer Plitsch, Alexander Hastings and Ian Brekke
Subject MatterAdministrative

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT